JPRN-UMIN000053714尚未招募Unknown
A study on the safety and efficacy of semaglutide in obese patients - A study on the safety and efficacy of semaglutide in obese patients
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe anemia (Hb level < 10 g/dL) 2. Patients using implanted medical devices (such as pacemakers) 3. Patients with active malignant tumors 4. Participants for whom the principal investigator or collaborating investigator has deemed participation in this clinical study inappropriate 5. Pregnant women or women who may be pregnant
研究者
相似试验
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageEUCTR2018-004484-31-DEovo Nordisk A/S69
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageNon-alcoholic steatohepatitis Compensated liver cirrhosisMedDRA version: 20.1 Level: PT Classification code 10053219 Term: Non-alcoholic steatohepatitis System Organ Class: 10019805 - Hepatobiliary disordersMedDRA version: 20.0 Level: LLT Classification code 10024667 Term: Liver cirrhosis System Organ Class: 10019805 - Hepatobiliary disordersEUCTR2018-004484-31-ESovo Nordisk A/S69
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageEUCTR2018-004484-31-GBovo Nordisk A/S69
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageEUCTR2018-004484-31-FRovo Nordisk A/S71
尚未招募
2 期
Semaglutide for post-liver transplant obesityOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMetabolic syndromeLiver transplantDiet and Nutrition - ObesitySurgery - Other surgeryObesityACTRN12621001739808Austin Health100